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Objectives: The objective of this study was to isolate a Brucella lonmutant and to
analyze the cytokine response of B. lonmutant during macrophage infection.
Methods: A wild-type Brucella abortus strain was mutagenized by Tn5 trans-
position. From the mouse macrophage J774.A1 cells, total RNA was isolated at
0 hours, 6 hours, 12 hours, and 24 hours after infection with Brucella. Using mouse
cytokine microarrays, we measured transcriptional levels of the cytokine response,
and validated our results with a reverse transcriptase-polymerase chain reaction
(RT-PCR) assay to confirm the induction of cytokine messenger RNA (mRNA).
Results: In host J774.A1 macrophages, mRNA levels of T helper 1 (Th1)-type cyto-
kines, including tumor necrosis factor-alpha (TNF-a), interferon-gamma (IFN-g),
interleukin-2 (IL-2), and IL-3,were significantly higher in the lonmutant compared to
wild-type Brucella and the negative control. TNF-a levels in cell culture media were
induced as high as 2 mg/mL after infectionwith the lonmutant, a greater than sixfold
change.
Conclusion: In order to understand the role of the lon protein in virulence, we
identified and characterized a novel B. lon mutant. We compared the immune
response it generates to the wild-type Brucella response in a mouse macrophage
cell line. We demonstrated that the B. lon mutants induce TNF-a expression from
the host J774.A1 macrophage.1. Introduction
Brucellosis is an important zoonotic disease affecting
many mammalian species, and it can be transmitted to
humans [1]. Brucellosis is caused by Brucella species,
which are small, gram-negative coccobacilli, and thisted under the terms of the C
0) which permits unrestrict
roperly cited.
ase Control and Preventionfacultative intracellular bacterial pathogen is capable of
causing abortion and male infertility in animals. Brucella
abortus causes abortion in cattle and chronic infections in
humans, and symptoms include undulant fever, endo-
carditis, and arthritis [2]. Prevention of brucellosis in
livestock is achieved using a laboratory-derived vaccinereative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
302 S. Park, et alstrain, which induces the production of antibodies to
Brucella. There is no available human vaccine [3].
The cell-mediated immune response to brucellosis in-
cludes the production of cytokines that activate macro-
phages for antibrucella activities. However the
mechanisms by which these cytokines lead to macrophage
activation are complex [4]. Macrophages are particularly
important for the survival and spread of Brucella during
infection. Among the key activities of cytokines, gamma
interferon has been shown to induce antimicrobial activ-
ities against a variety of intracellular pathogens, and tumor
necrosis factor (TNF) can elevate macrophage stimulating
factor and increasesH2O2 production and nitrite release [5].
B. abortus avoids stimulation of the host immune
system, permitting the establishment of chronic infec-
tion. Some Brucella species inhibit host cell apoptosis,
similar to Chlamydia, Bartonella henselae, and Myco-
bacterium bovis. Generally, B. abortus infection induces
minimal levels of cytokines [6,7].
Lon protease contributes to the degradation of short-
lived, misfolded, or damaged proteins by environmental
changes, and seems to play an important role as a chap-
erone [8]. In Escherichia coli, lon is responsible for
adenosine triphosphate-dependent proteolysis and is
thought to play a major role in the response to environ-
mental stress by downregulating SulA, an inhibitor of cell
division, and by modulating the activity of the tran-
scriptional activator RcsA [9,10]. In previous research, a
lon mutant of Brucella was studied for its response to
environmental stress conditions and the role of lon in the
maintenance of chronic infection was investigated in the
mouse model. Although the biochemical functions of
B. abortus lon mutant and its effect on Brucella patho-
genesis both in vivo and in vitro were investigated more
than 10 years ago, the induction of TNF-a inmacrophages
infected by Brucella lonmutant has not yet been reported
[11]. TNF-a is an important player in the apoptotic
pathway and may be involved in directing cell death to-
ward apoptotic or necrotic pathways. Furthermore, TNF-
a mRNA expression peaks at early infection times with
E. coli K12 or heat-killed Brucella-infected cells. How-
ever, there is no expression of mRNAs encoding TNF-a
in live Brucella infected cells. For example, Brucella suis
infected macrophages express interleukin (IL)-1, IL-6,
IL-10, IL-8, but do not express TNF-a [12]. The
viability of the B. lon mutant during infection and its ef-
fect on the immune response are largely unknown.2. Materials and methods
2.1. Bacteria growth conditions
The characteristics of Brucella strains were confirmed
by using AMOS (B. abortus-Brucella melitensis-Brucella
ovis-B. suis) polymerase chain reactions (PCRs). The
bacterial strains used were B. abortus 2308, wild-type
strain of B. abortus (parent strain of lon mutant) and lonmutant.We isolated the wild-type strain ofB. abortus from
the blood sample of the patient and seeded inBrucella agar
plate. Briefly, this wild-type strain of B. abortus was iso-
lated from blood cultures of a 33-year-old man with acute
brucellosis, who presented with fever [13]. To confirm
bacterial species, genomic DNA was isolated from sam-
ples of B. abortus, wild-type Brucella strain and lon
mutant, and PCR amplification of 16S ribosomal RNA
(rRNA) was performed. Brucella strains were cultured in
tryptic soy broth (TSB; Difco, Detroit, MI, USA) medium
at 37 C in an atmosphere containing 5%CO2. Kanamycin
was added at a concentration of 50mg/mL unless otherwise
indicated. E. coli strains were cultured at 37 C in Luria-
Bertani (LB) medium. All work with live B. abortus was
performed at biosafety level 3. The J774.A1 macrophage
cell line was purchased from the American Type Culture
Collection (Manassas, VA, USA). The cells were cultured
at 37 C with 5% CO2 in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% heat-
inactivated fetal bovine serum (Atlanta Biologicals, Nor-
cross, GA, USA). During Brucella infection, cell viability
was evaluated by trypan blue exclusion assay. Apoptotic
and necrotic cells were analyzed by flow cytometry
(FAScan, BD Bioscience, San Jose, CA, USA) using
Annexin V-FITC/propidium iodide (PI) detection kit
(ApoScan, BioBud, Seoul, Korea).
2.2. Construction of Brucella mutant library
The mini-Tn5Km2-bearing plasmid pUT mini-
Tn5Km2 was introduced into wild-type B. abortus
isolate from an E. coli K-12 derivative, SM17lpir, by
conjugation. The pUT vector containing mini-Tn5Km2
was kindly provided by Professor S. Kim, College of
Veterinary Medicine, Gyeongsang National University,
Korea. The obtained mutants were isolated from Bru-
cella agar plates containing kanamycin (30 mg/mL). The
chromosomal DNA from mutants was digested with
EcoRI, cloned to plasmid pBluescript II KS(þ), trans-
formed into E. coli DH5a, and plated onto LB agar plate
containing ampicillin (100 mg/mL) and kanamycin
(30 mg/mL). Plasmid DNA from colony was extracted
by using the plasmid Mini Kit (Qiagen, Valencia, CA,
USA), and the chromosomal DNA sequence was
analyzed by using the mini-Tn5Km2 transposon O’-end
primer (5’-CCTCTAGAGTCGACCTGCAG-3’).
2.3. RNA isolation, reverse transcriptase-
polymerase chain reaction, and microarray
analysis
Brucella cultures derived from different Brucella
colonies were used to infect different groups of macro-
phage cells to obtain independent infections. Following
1.5-hour incubation at 37 C in 5% CO2, the cells were
washed three times with phosphate buffered saline
(PBS). At 0 hours (no Brucella infection) and at 30
minutes, 1 hour, and 24 hours postinfection, 7.5 mL of
Table 1. Primers for reverse transcriptase-polymerase chain reaction used in this study





TNF Z tumor necrosis factor.
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USA) was added to each flask in a group. Uninfected
J774.A1 cells were counted to determine the value for
0 hours postinfection. The homogenized samples were
incubated for 5 minutes at room temperature. All RNA
samples were further purified using the RNeasy mini kit
(Qiagen) according to the manufacturer’s instructions
and resuspended in RNase-free water. Prior to use, the
integrity and concentration of each RNA sample was
checked using an Agilent 2100 BioAnalyzer and
NanoDrop instrument. RNA samples had a total RNA
profile exhibiting a 28S band approximately two times
more intense than the 18S ribosomal band and an A260/
A280 ratio of 1.9. Primers were designed using the
Primer software and were purchased from Bioneer
(Daejeon, Korea). To confirm microarray data, the same
triplicate biological RNA samples were used for reverse
transcriptase-polymerase chain reaction (RT-PCR)
experiment. To determine if the changes in cell growth
and cell density influenced the macrophage gene
expression profiles, only DMEM was added to unin-
fected J774.A1 cell cultures at 0 hours, 6 hours, 12
hours, and 24 hours with 0 hours defined as it was for
the microarray experiment. Twenty nanograms of RNA
was used for reverse transcription reaction (Superscript
reverse transcription kit, Invitrogen). The primer pair for
b2 microglobulin was used for internal housekeeping
gene control (Table 1). The PCR conditions were as
follows: initial denaturation at 95 C for 3 minutes,
followed by 35 cycles at 95 C for 1 minute, at 55 C for
1 minute, and at 72 C for 1 minute. PCR products were
separated on 1.2% agarose gel and photographed. Band
intensities were quantified using Chemi analysis
(Amersham Pharmacia, Piscataway, USA). For test
RNAs, synthesis of target complementary DNA (cDNA)
probes and hybridization were performed using Agi-
lent’s Low RNA Input Linear Amplification kit (Agilent
Technology, Palo Alto, CA, USA) according to the
manufacturer’s instructions. Briefly, cDNA master mix
was prepared and added to the reaction mixer. The hy-
bridized images were scanned using Agilent’s DNA
microarray scanner and quantified with Feature Extrac-
tion Software (Agilent Technology). All data normali-
zation and selection of fold-changed genes were
performed using GeneSpringGX 7.3 (Agilent Technol-
ogy). The averages of normalized ratios were calculated
by dividing the average of normalized signal channel
intensity by the average of normalized control channelintensity. Functional annotation of genes was performed
according to Gene Ontology Consortium (http://www.
geneontology.org/index.shtml) by GeneSpringGX 7.3.
2.4. Infection of J774A.1 murine macrophages
and analysis of cytokines secretion
J774.A1 macrophage cells were plated in 24-well
plates in DMEM. The J774.A1 cells were then infected
with B. abortus strains in triplicate wells of a 24-well
plate at a multiplicity of infection (MOI) of 50:1.
Following 1.5 hours of incubation at 37 C in atmo-
sphere containing 5% CO2, the cells were washed three
times with phosphate-buffered saline. Infected cells
were lysed with distilled water at 0, 6, 12, and 24 hours
postinfection. In addition, supernatants from Brucella
infected J774.A1 were collected and analyzed for IL-2,
IL-4, IL-5, IL-10, IL-12(P70), granulocyte-macrophage
colony-stimulating factor (GM-CSF), IFN-g, and TNF-
a by Bio-Plex Cytokine Assay (Mouse Th1/Th2 Panel,
Bio-Rad Laboratories, Hercules, CA, USA) according to
the manufacturer’s instructions. Bacterial infection and
intracellular survival assay were done by modified Kim
et al’s method [14]. Briefly, B. abortus strains were
inoculated in J774.A macrophage grown on a 96-well
plate with DMEM with 10% fetal bovine serum. After
1.5 hours incubation, cells were washed twice with 0.2
mL of sterile PBS and incubated with DMEM containing
10% FBS. At each time point, cells were washed three
times with PBS and were lysed with distilled water. The
colony formation unit (CFU) was measured by serial
dilutions on Brucella agar plates.
2.5. Statistical analysis
The nonparametric trend test was used for compari-
son of replication rate in host cell between the Brucella
lon mutant, B. abortus 2308, and B. abortus wild-type
strain. The analysis was performed using the SAS
version 9.1 software packages (SAS Institute Inc., Cary,
NC, USA). Differences were considered statistically
significant at r < 0.05.3. Results
3.1. Construction and culture of B. abortus lon
mutant
In order to select a B. abortus lon mutant from
mutant library, primary screening was performed using
304 S. Park, et algenomic DNA digestion. Genomic EcoRI fragments
containing the Tn5 insertion were isolated and identified
by sequencing analysis. The results from the cloning
revealed that Tn5 was inserted into a gene whose pu-
tative protein product has homology to the lon protein.
Sequence of the open reading frame of the lon gene
confirmed that Tn5 was inserted to its C-terminal region
(409th amino acid). We studied the B. lon mutant for
in vitro phenotypes that might differentiate it from the
wild-type. Comparisons of the growth characteristics of
the lon mutant versus wild-type Brucella revealed that
their exponential growth rates in rich medium and
intracellular growth within J774A.1 macrophage cells
were the same (Figure 1).
3.2. Cytokine response of macrophage during
lon mutant infection
To clarify the macrophage cytokine response dur-
ing B. lon mutant infection, a time course of micro-
array analysis was performed at 0 hours, 6 hours, 12
hours, and 24 hours postinfection. The mRNAs whose
levels changed more than twofold compared with the
levels in the controls were considered in the micro-
array results. The expressed genes in J774.A1 mac-
rophages were calculated as the normalized fold
change during lon mutant infection. The gene encod-
ing Cxcl10 was the most significantly overexpressed
in J774A.1 by B. lon mutant postinfection. Upregu-
lated TNF-a was observed after infection with Bru-
cella (Table 2). By Kyoto Encyclopedia of Genes and
Genomes pathway analysis, we confirmed that genes
encoding proteins involved in TNF signaling were
more expressed in the cytokine microarray results.
The gene encoding TNF-a was significantly upregu-
lated (6.61-fold) by 6 hours, and TNF receptor wasFigure 1. Intracellular localization of Brucella abortus wild-type
with B. abortus wild-type (upper panel) or lon mutant (lower pane
against Brucella in the same field. The results were evaluated by
cyanate (FITC) filter (B and E), and Hoechst staining (C and F) foalso upregulated (7.78-fold) at later infection times.
To validate this upregulation we analyzed TNF-a
mRNA (446 bp) transcription by RT-PCR. TNF-a
expression was detected in the early stage of lon
mutant infection at 6 hours postinfection. TNF-a
transcription was not increased in the control groups
(no infection, B. abortus, and wild-type Brucella) until
12 hours postinfection (Figure 2).
3.3. TNF-a response
To examine the expression of TNF-a protein, the
supernatants of uninfected and Brucella infected
J774.A1 macrophages were collected at different time
points, and the concentrations of cytokines released
from macrophages were determined. Secretion of TNF-
a after 6 hours of cell culture in J774.A1 ranged from
8.5 ng/mL up to very high levels of 1,068 ng/mL after 1
day of infection (Figure 3). In addition, the expression of
IL-12b, IL-10, and GM-CSF were detected at only a
very low level (1-36 pg/mL) in culture media under all
conditions. IL-10 expression was also increased (20 pg/
mL) during infection at the 24-hour time point.
3.4. Growth of lon mutant
We wanted to exclude the hypothesis that the effect
of Brucella proliferation in infected J774.A1 cells is
due to a difference in growth rate. We confirmed the
doubling time in broth medium and also performed
intracellular replication assays in J774A.1 macrophage
cells using the B. lon mutant, B. abortus 2308, and B.
abortus wild-type strain. J774.A1 cells were infected
with B. lon mutant, B. abortus 2308, or B. abortus
wild-type strain. After that, numbers of viable CFU
were determined at 1 hour, 6 hours, 12 hours, 24 hours,
and 48 hours postinfection (data not shown). Viabilityand lon mutant in J774.A1 cells. The J774.A1 cells infected
l) for 6 hours were fixed and stained with an antibody directed
bright-field photomicrographs (A and D), fluorescein isothio-
r nuclei. All panels, 400.
Table 2. Messenger RNA expression of upregulated cytokine genes during lon mutant infection between 6 hours and 24 hours
postinfection
Normalized fold Accession number Gene symbol Description
6 h
11.23 NM_021274 Cxcl10 Chemokine ligand 10
6.61 NM_013693 Tnf Tumor necrosis factor
5.52 NM_008352 IL2b Interleukin 12b
5.27 NM_009425 Tnfefl0 Tumor necrosis factor
superfamily,
member 10
4.47 NM_010510 Ifnb1 Interferon beta 1
3.69 NM_011577 Tgfb1 Transforming growth
factor, beta 1
12 h
7.9 NM_021274 Cxcl10 Chemokine ligand 10




6.81 NM_013653 Ccl5 Chemokine ligand 5
4.21 NM_010554 Il1a Interleukin 1 a
3.8 NM_011577 Tgfb1 Transforming growth
factor, beta 1
3.18 NM_009425 Tgfsf10 Tumor necrosis factor
superfamily,
member 10
3.08 NM_028679 Irak3 Interleukin-1 receptor-
associated kinase 3
3.07 AK156231 Ccnt2 Cyclin T2
24 h
5.44 NM_197889 Ifnz Interferon zeta
5.16 NM_009425 Tnfsf10 Tumor necrosis factor
superfamily,
member 10
4.57 NM_013653 Ccl5 Chemokine ligand 5
4.25 NM_008003 Fgf15 Fibroblast growth
factor 15
3.68 NM_016673 Cntfr Ciliary neurotrophic
factor receptor
3.54 NM_021274 Cxcl10 Chemokine ligand 10
3.36 NM_011888 Ccl19 Chemokine ligand 19
3.35 NM_011577 Tgfb1 Transforming growth
factor, beta 1
3.31 NM_021887 Il21r Interleukin 21 receptor




Lon mutant of Brucella abortus 305assays showed that the lon mutant gave similar number
of CFUs as its parent strain at 6 hours postinfection. In
infected J774A.1 cells, the replication of wild-type
Brucella (p Z 0.0392) and lon mutant (p Z 0.0157)
increased significantly in a time dependent manner,
which is consistent with the results obtained with a
CFU measurement. The replication of B. abortus
(p Z 0.0517) also increased but the increase was not
significant statistically.4. Discussion
Brucella alters the expression of many genes to adapt
to harsh conditions in the host cell and to survive against
the host immune system. The intracellular survival of B.
abortus has been documented, and it is incorporated into
phagosomes and localized to ER like structures in
J774.A1 macrophages [15,16]. The macrophage is a
central means of defense against microbial pathogens
Figure 2. The messenger RNA expression of tumor necrosis factor (TNF)-a during early infection. The level of TNF-a was
determined from the J774.A1 cells infected with Brucella abortus, wild-type Brucella, or the lon mutant [multiplicity of infection
(MOI) Z 50] by reverse transcriptase-polymerase chain reaction.
306 S. Park, et althat kill microorganisms by ingestion. Based on previ-
ous studies, it is clear that macrophages play a major
role in killing Brucella. In acute infection of B. abortus,
the early immune response is critical to controlling
infection. For examples, the activation of neutrophil was
accomplished in 60 minutes and early neutrophil acti-
vation is followed by IL-8 induction. Mature neutrophil
survival and apoptosis are influenced by the inflamma-
tory cytokines [17].
In this study, the transcription and expression of
TNF-a was analyzed in the J774.A1 cell line using both
RT-PCR on extracted RNA and cytokine assays on su-
pernatant culture media. A significant increase in TNF-a
was detected at many time points. The transcript level
for TNF-a was dramatically elevated as early as 6 hours
after infection with the B. lon mutant in this study. The
B. lon mutant may be involved in TNF-a mediated cell
death toward an apoptotic or necrotic pathway. TNF-a is
one of the products of macrophage response directly
involved in the killing of Brucella and the mechanism
regulating the TNF-a production in target cells has not
yet been clearly defined. The concentration of TNF-a
was measured in infected cell media in the amount ofFigure 3. The protein expression of tumor necrosis factor (TNF)
from the medium of J774.A1 cells infected with Brucella abortus,
(MOI) Z 50] using enzyme-linked immunosorbent assay.0.5e30 ng/mL during 1 day postinfection based on
previous studies [18,19]. This suggests that apoptosis or
macrophage cell death occurs in J774.A1 cells infected
with lon mutant in this study.
Brucella requires enough time for the preparation of
growth avoiding the host immune system and space for
the Brucella replication to be a successful infection
[20,21]. It has been shown that the replication rate of
Brucella in macrophages decreases during the first 12
hours of infection. This decrease seems to be necessary
for intracellular adaptation of lon mutant from media
culture condition. Recently, other groups have reported
similar findings in virulent Brucella strain [22,23]. The
recovery mechanisms and metabolic pathway proteins to
establish intracellular Brucella adaptation were eluci-
dated by a comprehensive analysis of its proteomes.
Because survival and replication in host cells is impor-
tant when determining whether mutated gene influences
the virulence of Brucella, we examined the intracellular
replication of Brucella strains in J774.A1 macrophage
cells. We cannot rule out that the decreased viability of
the lon mutants is a result of the host macrophages
rapidly killing of cells during early infection. The ability-a during early infection. The level of TNF-a was determined
wild-type Brucella, or the lon mutant [multiplicity of infection
Lon mutant of Brucella abortus 307of the lon mutant to proliferate is similar to wild-type B.
abortus and B. abortus 2308 in J774A.1 macrophage
cells at 24 hours postinfection. By contrast, the majority
of Brucella cells were killed during the first 24 hours,
whereas the surviving bacteria began to replicate 24
hours postinfection. This type of mutant survival pattern
is consistent with one report [24].
In Brucella lon mutants, our microarray study is the
first to show that macrophage cytokine gene expression
changes occur at an early infection stage. The most
significant finding of this work is the identification of the
host cell response during B. lon mutant infection and
secondly is the correlation between the virulence of the
lon mutant and macrophage viability. To better under-
stand the role lon plays in Brucella’s ability to evade
host immune mechanisms and establish chronic infec-
tion, we compared transcriptional profiles of the host
cytokine response to infection with wild-type and lon
mutant Brucella strains.Acknowledgments
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